Rachel K. King

Companies

• Fulcrum Therapeutics (United States)Board member Nov 14, 2024 to now¹
• NovavaxBoard member Nov 2, 2018 to now²
• CRESCENT BIOPHARMA, INC.Board member Jan 9, 2014 to May 1, 2024³
• CRESCENT BIOPHARMA, INC.Chief executive officer Jan 9, 2014 to Jan 22, 2021³
• CRESCENT BIOPHARMA, INC.President Jan 9, 2014 to Jan 22, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CBCRESCENT BIOPHARMA, INC. CBIO560,935 shares⁴$7.0M at $12.47Apr 2, 2024
• Novavax NVAX45,170 shares⁵$488.7K at $10.82Jun 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 20, 2026Exercised options 18,880 shares of Novavax⁵
• Jun 12, 2025Exercised options 10,420 shares of Novavax⁶
• Dec 13, 2024Sold 4,150 shares at $9.02 of Novavax⁷
• Jun 12, 2024Exercised options 6,670 shares of Novavax⁸
• Mar 29, 2024Granted 3,334 shares at $3.00 of CRESCENT BIOPHARMA, INC.⁴
• Dec 29, 2023Granted 4,238 shares at $2.36 of CRESCENT BIOPHARMA, INC.⁹
• Sep 30, 2023Granted 6,667 shares at $1.50 of CRESCENT BIOPHARMA, INC.¹⁰
• Jun 10, 2023Exercised options 3,100 shares of Novavax¹¹
• Aug 2, 2022Inherited 7,500 shares of CRESCENT BIOPHARMA, INC.¹²
• Jun 17, 2022Exercised options 700 shares of Novavax¹³
• Feb 15, 2022Inherited 11,641 shares of CRESCENT BIOPHARMA, INC.¹²